ACSS3 and cancer: The results of Table S2 indicated that cancer patients with lower ACSS3 expression had significantly shorter disease-free time, in both multivariate analysis (HR 0.575, 95% CI 0.36-0.91, P = 0.018) and univariate analysis (HR 0.563, 95% CI 0.36-0.89, P = 0.013), as shown in Table S1.